摘要
Abstract
Objective To investigate the different clinical efficacy of alendronate sodium and Caltrate D for treating postmenopausal os-teoporosis. Methods Totally 80 patients with postmenopausal osteoporosis in our hospital from January 2015 to September 2016 were divided into the control group ( treatment of Caltrate D ) and the observation group ( treatment of alendronate sodium ) according to the random number method, 40 patients in each group. The clinical efficacy, the symptoms improvement time and disappearance time, and the bone mineral density changes of L1 -4, femoral neck, trochanter and total hip in two groups were compared before and after treat-ment. Results Compared with the control group, the total effective rate of the observation group was significantly increased ( P < 0. 05 ) . the symptoms improvement time and disappearance time of the observation group were obviously shorter ( P < 0. 05 ) , after treatment, the bone mineral density of L1 -4, femoral neck, trochanter and total hip were significantly increased in the observation group ( P < 0. 05 ) . Conclusion Compared with Caltrate D, alendronate sodium can improve the bone mineral density in patients with postmenopausal osteo-porosis, and increase clinical efficacy.关键词
阿仑膦酸钠/钙尔奇D/绝经后骨质疏松/骨密度Key words
alendronate sodium/Caltrate D/postmenopausal osteoporosis/bone mineral density分类
医药卫生
